Flputnam Investment Management Co. Buys 10,799 Shares of Astera Labs, Inc. $ALAB

Key Points

• Flputnam Investment Management more than doubled its position in Astera Labs during the fourth quarter, buying an additional 10,799 shares and bringing its total stake to 20,063 shares valued at about $3.34 million.
• Astera Labs continues to draw institutional interest, with 60.47% of shares held by institutional investors and several smaller funds recently adding to or initiating positions in the stock.
• The company reported strong quarterly results, beating earnings and revenue estimates with $0.61 EPS on $308.36 million in revenue, while also seeing significant insider selling and mixed analyst sentiment, including a recent downgrade from Northland Securities.

Flputnam Investment Management Co. raised its stake in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 116.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 20,063 shares of the company's stock after purchasing an additional 10,799 shares during the period. Flputnam Investment Management Co.'s holdings in Astera Labs were worth $3,338,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Assetmark Inc. increased its stake in Astera Labs by 374.1% in the third quarter. Assetmark Inc. now owns 128 shares of the company's stock valued at $25,000 after purchasing an additional 101 shares in the last quarter. Hilltop National Bank increased its stake in Astera Labs by 100.0% in the fourth quarter. Hilltop National Bank now owns 200 shares of the company's stock valued at $33,000 after purchasing an additional 100 shares in the last quarter. Aventura Private Wealth LLC acquired a new position in shares of Astera Labs during the fourth quarter valued at about $33,000. Wexford Capital LP acquired a new position in shares of Astera Labs during the third quarter valued at about $39,000. Finally, National Bank of Canada FI grew its holdings in shares of Astera Labs by 159.0% during the third quarter. National Bank of Canada FI now owns 202 shares of the company's stock valued at $39,000 after buying an additional 124 shares during the last quarter. 60.47% of the stock is owned by institutional investors.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs announced it will host press conferences, live demos, and technical talks at Computex 2026, where it plans to showcase its AI connectivity portfolio, including the Scorpio X-Series 320 Lane Smart Fabric Switch, optical connectivity, and COSMOS-enabled validation tools. The event should help support visibility with analysts, customers, and ecosystem partners. Article Title
• Positive Sentiment: The company’s recent conference presentation at TD Cowen and broader analyst attention keep the focus on Astera Labs’ AI infrastructure growth story and product roadmap. Article Title
• Neutral Sentiment: Northland Securities downgraded ALAB from outperform to market perform, which may cap some near-term enthusiasm but does not signal a major change in the company’s fundamentals.
• Negative Sentiment: Insider selling remains a notable overhang, including COO Sanjay Gajendra’s large prearranged sale of 400,000 shares and General Counsel Philip Mazzara’s sale of 796 shares. Even though these trades were disclosed and one was made under a 10b5-1 plan, heavy insider selling can weigh on investor sentiment. Article Title

Insiders Place Their Bets

In other Astera Labs news, General Counsel Philip Mazzara sold 796 shares of Astera Labs stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $291.03, for a total value of $231,659.88. Following the sale, the general counsel owned 103,343 shares of the company's stock, valued at approximately $30,075,913.29. The trade was a 0.76% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Sanjay Gajendra sold 400,000 shares of Astera Labs stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the sale, the chief operating officer directly owned 5,064,213 shares in the company, valued at approximately $1,470,141,033.90. This represents a 7.32% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 2,316,257 shares of company stock valued at $474,860,636. Company insiders own 12.50% of the company's stock.

Astera Labs Stock Performance

Astera Labs stock opened at $325.33 on Thursday. Astera Labs, Inc. has a fifty-two week low of $84.78 and a fifty-two week high of $326.97. The stock has a market cap of $55.76 billion, a PE ratio of 219.82, a price-to-earnings-growth ratio of 4.22 and a beta of 3.35. The firm's 50-day simple moving average is $182.05 and its 200 day simple moving average is $162.57.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.07. The business had revenue of $308.36 million for the quarter, compared to analysts' expectations of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm's revenue for the quarter was up 93.5% compared to the same quarter last year. During the same period in the previous year, the company earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, analysts predict that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

ALAB has been the subject of a number of analyst reports. UBS Group initiated coverage on shares of Astera Labs in a report on Tuesday, April 21st. They set a "neutral" rating and a $180.00 price objective for the company. Morgan Stanley lifted their price objective on shares of Astera Labs from $210.00 to $240.00 and gave the company an "overweight" rating in a report on Wednesday, May 6th. Rothschild & Co Redburn initiated coverage on shares of Astera Labs in a report on Friday, May 1st. They set a "neutral" rating and a $153.00 price objective for the company. Jefferies Financial Group reiterated a "buy" rating and set a $270.00 price objective on shares of Astera Labs in a report on Wednesday, May 6th. Finally, Citigroup cut shares of Astera Labs from a "buy" rating to a "market perform" rating in a report on Tuesday. Twelve equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $233.75.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.